However, despite the lower frequency of Class I mutations in lung cancer compared to other malignancies, lung cancer represented the largest number of patients with BRAF alterations across all cancers surveyed, given the large of number of patients diagnosed annually10,11 (Fig. 1a and Supplementary Fig. 1b). The gene discussed is BRAF; the disease is lung cancer.